Jan A Burger (Jan Burger)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 39

Top Topics

Long Noncoding Rna

Disease Activity

Chronic Lymphocytic Leukemia

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, Ruparoshni Jayabalan, Hannah Briesch, Ramon Massoni-Badosa, Pavle Boskovic, Julian Beckendorff, Tobias Roider, Lavinia Arseni, Mariana Coelho, Supriya Chakraborty, Alicia Vaca, Mariela Sivina, Markus Muckenhuber, Sonia Rodriguez-Rodriguez, Alice Bonato, Sophie A Herbst, Marc Zapatka, Clare Sun, Helene Kretzmer, Thomas Naake, Peter-Martin Bruch, Felix Czernilofsky, Elisa Ten Hacken, Martin Schneider, Dominic Helm, Deyan Yordanov Yosifov, Joseph Kauer, Alexey V Danilov, Moritz Bewarder, Kristina Heyne, Christof Schneider, Stephan Stilgenbauer, Adrian Wiestner, Jan-Philipp Mallm, Jan A Burger, Dimitar G Efremov, Peter Lichter, Sascha Dietrich, José Ignacio Martín-Subero, Karsten Rippe, Martina Seiffert
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances (2024)
Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, Ruparoshni Jayabalan, Hannah Briesch, Ramon Massoni-Badosa, Pavle Boskovic, Julian Benckendorff, Tobias Roider, Lavinia Arseni, Mariana Coelho, Supriya Chakraborty, Alicia M Vaca, Mariela Sivina, Markus Muckenhuber, Sonia Rodriguez-Rodriguez, Alice Bonato, Sophie A Herbst, Marc Zapatka, Clare Sun, Helene Kretzmer, Thomas Naake, Peter-Martin Bruch, Felix Czernilofsky, Elisa Ten Hacken, Martin Schneider, Dominic Helm, Deyan Yordanov Yosifov, Joseph Kauer, Alexey V Danilov, Moritz Bewarder, Kristina Heyne, Christof Schneider, Stephan Stilgenbauer, Adrian Wiestner, Jan-Philipp Mallm, Jan A Burger, Dimitar G Efremov, Peter Lichter, Sascha Dietrich, José Ignacio Martin-Subero, Karsten Rippe, Martina Seiffert
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood 144 (5) (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, Ruparoshni Jayabalan, Hannah Briesch, Ramon Massoni-Badosa, Pavle Boskovic, Julian Benckendorff, Tobias Roider, Lavinia Arseni, Mariana Coelho, Supriya Chakraborty, Alicia M Vaca, Mariela Sivina, Markus Muckenhuber, Sonia Rodriguez-Rodriguez, Alice Bonato, Sophie A Herbst, Marc Zapatka, Clare Sun, Helene Kretzmer, Thomas Naake, Peter-Martin Bruch, Felix Czernilofsky, Elisa Ten Hacken, Martin Schneider, Dominic Helm, Deyan Yordanov Yosifov, Joseph Kauer, Alexey V Danilov, Moritz Bewarder, Kristina Heyne, Christof Schneider, Stephan Stilgenbauer, Adrian Wiestner, Jan-Philipp Mallm, Jan A Burger, Dimitar G Efremov, Peter Lichter, Sascha Dietrich, José Ignacio Martin-Subero, Karsten Rippe, Martina Seiffert
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood 144 (5) (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D D DiNardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alicia M Vaca, Nikolaos Ioannou, Mariela Sivina, Elisavet Vlachonikola, Karen Clise-Dwyer, Ekaterina Kim, Dan Li, Qing Ma, Alessandra Ferrajoli, Zeev E Estrov, William G Wierda, Piers E M Patten, Alan G Ramsay, Jan A Burger
Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures. Leukemia 36 (5) (2022)
Binyamin Asher Knisbacher, Ziao Lin, Cynthia K Hahn, Ferran Nadeu, Martí Duran-Ferrer, Kristen E Stevenson, Eugen Tausch, Julio Delgado, Alex Barbera-Mourelle, Amaro Taylor-Weiner, Pablo Bousquets Muñoz, Ander Díaz-Navarro, Andrew Dunford, Shankara Anand, Helene Kretzmer, Jesus Gutierrez-Abril, Sara López-Tamargo, Stacey M Fernandes, Clare Sun, Mariela Sivina, Laura Z Rassenti, Christof Schneider, Shuqiang Li, Laxmi Parida, Alexander Meissner, François Aguet, Jan A Burger, Adrian Wiestner, Thomas J Kipps, Jennifer R Brown, Michael Hallek, Chip Stewart, Donna S Neuberg, José Ignacio Martin-Subero, Xose S Puente, Stephan Stilgenbauer, Catherine J Wu, Elias Campo, Gad A Getz
Molecular map of chronic lymphocytic leukemia and its impact on outcome. Nature genetics 54 (11) (2022)
Nitin Jain, Jayastu Senapati, Beenu Thakral, Alessandra Ferrajoli, Phillip A Thompson, Jan A Burger, Sreyashi Basu, Tapan M Kadia, Naval G Daver, Gautam Borthakur, Marina Konopleva, Naveen Pemmaraju, Erin M Parry, Catherine J Wu, Joseph D Khoury, Carlos E Bueso-Ramos, Naveen Garg, Xuemei Wang, Wanda Lopez, Ana Ayala, Susan M O'Brien, Hagop M Kantarjian, Michael J Keating, James P Allison, Padmanee Sharma, William G Wierda
A Phase 2 Study of Nivolumab Combined with Ibrutinib in Patients with Diffuse Large B-cell Richter Transformation of CLL. Blood advances (2022)
Paul M Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Jan A Burger, Peter Hillmen, Steve E Coutre, Claire Dearden, Sebastian Grosicki, Helen McCarthy, Jian-Yong Li, Fritz Offner, Carol Moreno, Cathy Zhou, Emily Hsu, Anita Szoke, Thomas J Kipps, Paolo Ghia
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia. Blood advances 6 (11) (2022)
Ti'ara L Griffen, Fieke W Hoff, Yihua Qiu, James W Lillard, Alessandra Ferrajoli, Phillip A Thompson, Endurance Toro, Kevin Ruiz, Jan A Burger, William G Wierda, Steven Mitchell Kornblau
Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets. Blood cancer journal 12 (3) (2022)
Anneke D van Dijk, Ti'ara L Griffen, Yihua H Qiu, Fieke W Hoff, Endurance Toro, Kevin Ruiz, Peter P Ruvolo, James W Lillard, Eveline S J M de Bont, Jan A Burger, William G Wierda, Steven Mitchell Kornblau
RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences. Leukemia (2021)
Gavin Cull, Jan A Burger, Stephen Opat, David Gottlieb, Emma Verner, Judith Trotman, Paula Marlton, Javier Munoz, Patrick Johnston, David Simpson, Jennifer C Stern, Radha Prathikanti, Kenneth Wu, William Novotny, Jane Huang, Constantine S Tam
Zanubrutinib for treatment-naïve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 study. British journal of haematology 196 (5) (2021)
Mariela Sivina, Ekaterina Kim, William George Wierda, Alessandra Ferrajoli, Nitin Jain, Philip A Thompson, Hagop M Kantarjian, Michael J Keating, Jan A Burger
Ibrutinib induces durable remissions in treatment-naïve patients with CLL and 17p deletion/TP53 mutations. Blood (2021)
Hua-Jay J Cherng, Nadya Jammal, Shilpa Paul, Xuemei Wang, Koiji Sasaki, Philip Thompson, Jan A Burger, Alessandra Ferrajoli, Zeev E Estrov, Susan O'Brien, Michael Keating, William G Wierda, Nitin Jain
Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia. British journal of haematology 194 (1) (2021)
Gerardo Ferrer, Byeongho Jung, Pui Yan Chiu, Rukhsana Aslam, Florencia Palacios, Andrea Nicola Mazzarello, Stefano Vergani, Davide Bagnara, Shih-Shih Chen, Sophia Yancopoulos, Aliki Xochelli, Xiao-Jie Yan, Jan A Burger, Jacqueline C Barrientos, Jonathan E Kolitz, Steven L Allen, Kostas Stamatopoulos, Kanti R Rai, Barbara Sherry, Nicholas Chiorazzi
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL. Leukemia 35 (11) (2021)
Jan A Burger
CLL cells are moved by the MARCKS brothers. Blood 138 (7) (2021)
Warren C Fiskus, Christopher P Mill, Dimuthu Perera, Christine Birdwell, Qing Deng, Haopeng Yang, Bernardo H Lara, Nitin Jain, Jan A Burger, Alessandra Ferrajoli, John A Davis, Dyana T Saenz, Wendy Jin, Cristian Coarfa, Craig M Crews, Michael R Green, Joseph D Khoury, Kapil N Bhalla
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma. Leukemia 35 (9) (2021)
Nitin Jain, Phillip A Thompson, Jan A Burger, Alessandra Ferrajoli, Koichi Takahashi, Zeev E Estrov, Gautam Borthakur, Prithviraj Bose, Tapan Mahendra Kadia, Naveen Pemmaraju, Koiji Sasaki, Marina Y Konopleva, Elias J Jabbour, Naveen Garg, Xuemei Wang, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Wei Wang, Jeffrey Jorgensen, Sa Wang, Wanda Lopez, Ana Ayala, William Plunkett, Varsha Gandhi, Hagop M Kantarjian, Susan O'Brien, Michael Keating, William G Wierda
Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia 35 (12) (2021)
Rong Chen, Jennifer Tsai, Phillip A Thompson, Yuling Chen, Ping Xiong, Chaomei Liu, Francis Burrows, Mariela Sivina, Jan A Burger, Michael J Keating, William G Wierda, William Plunkett
The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action. Blood cancer journal 11 (3) (2021)
Cláudio Galvão de Castro Junior, Lauro Jose Gregianin, Jan A Burger
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection. Leukemia & lymphoma 61 (10) (2020)
Steven E Coutre, John C Byrd, Peter Hillmen, Jacqueline C Barrientos, Paul M Barr, Stephen Devereux, Tadeusz Robak, Thomas J Kipps, Anna Schuh, Carol Moreno, Richard R Furman, Jan A Burger, Michael E O'Dwyer, Paolo Ghia, Rudolph Valentino, Stephen Chang, James P Dean, Danelle F James, Susan M O'Brien
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies. Blood advances 3 (12) (2020)
Mariela Sivina, Lianchun Xiao, Ekaterina Kim, Alicia Vaca, Shih-Shih Chen, Michael J Keating, Alessandra Ferrajoli, Zeev Estrov, Nitin Jain, William G Wierda, Xuelin Huang, Nicholas Chiorazzi, Jan A Burger
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia. Leukemia 35 (6) (2020)
Paolo Strati, Koichi Takahashi, Christine B Peterson, Michael J Keating, Philip A Thompson, Naval G Daver, Nitin Jain, Jan A Burger, Zeev E Estrov, Susan M O'Brien, Hagop M Kantarjian, William G Wierda, P Andrew Futreal, Alessandra Ferrajoli
Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL. Blood advances 3 (9) (2020)
Boyu Hu, Keyur P Patel, Hsiang-Chun Chen, Xuemei Wang, Feng Wang, Rajyalakshmi Luthra, Mark J Routbort, Rashmi Kanagal-Shamana, Leonard J Medeiros, Cheng C Yin, Zhuang Zuo, Chi Young Ok, Sanam Loghavi, Guilin Tang, Francesco P Tambaro, Philip Thompson, Jan A Burger, Nitin Jain, Alessandra Ferrajoli, Prithviraj Bose, Zeev E Estrov, Michael J Keating, William G Wierda
Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments. British journal of haematology 185 (5) (2019)
Jan A Burger, Paula Cramer, Paul M Barr, Marie-Sarah Dilhuydy, Anthony Mato, John C Byrd, Stephen Chang, Thorsten Graef, Tony Lin, Alessandra Tedeschi
Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies. British journal of haematology 186 (1) (2019)
William G Wierda, John C Byrd, Susan O'Brien, Steven Coutre, Paul M Barr, Richard R Furman, Thomas J Kipps, Jan A Burger, Don A Stevens, Jeff Sharman, Paolo Ghia, Ian W Flinn, Cathy Zhou, Joi Ninomoto, Danelle F James, Constantine S Tam
Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia. British journal of haematology 186 (1) (2019)
Boyu Hu, Keyur P Patel, Hsiang-Chun Chen, Xuemei Wang, Rajyalakshmi Luthra, Mark J Routbort, Rashmi Kanagal-Shamana, L Jeffrey Medeiros, C Cameron Yin, Zhuang Zuo, Chi Young Ok, Sanam Loghavi, Guilin Tang, Francesco P Tambaro, Philip Thompson, Jan A Burger, Nitin Jain, Alessandra Ferrajoli, Prithviraj Bose, Zeev E Estrov, Michael Keating, William G Wierda
Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients. British journal of haematology 187 (3) (2019)
Constantine S Tam, Judith Trotman, Stephen Opat, Jan A Burger, Gavin Cull, David Gottlieb, Rosemary Harrup, Patrick B Johnston, Paula Marlton, Javier Munoz, John Francis Seymour, David Simpson, Alessandra Tedeschi, Rebecca Elstrom, Yiling Yu, Zhiyu Tang, Lynn Han, Jane Huang, William Novotny, Lai Wang, Andrew W Roberts
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL. Blood 134 (11) (2019)
Jan A Burger
New pieces in the BTKi resistance puzzle. Blood 131 (18) (2019)
Paolo Strati, Feng Wang, Francesco P Tambaro, Philip A Thompson, Jan A Burger, Nitin Jain, Alessandra Ferrajoli, Prithviraj Bose, Zeev E Estrov, Michael J Keating, Andrew Futreal, Koichi Takahashi, William G Wierda
The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype. British journal of haematology 187 (1) (2019)
Jennifer R Brown, Javid Moslehi, Michael S Ewer, Susan M O'Brien, Paolo Ghia, Florence Cymbalista, Tait D Shanafelt, Graeme Fraser, Simon A Rule, Steven E Coutre, Marie-Sarah Dilhuydy, Paula Cramer, Ulrich Jaeger, Martin Dreyling, John C Byrd, Steven P Treon, Emily Y Liu, Stephen Chang, Amulya Bista, Rama Vempati, Lisa Boornazian, Rudolph Valentino, Vijay Reddy, Michelle Mahler, Huiying Yang, Thorsten Graef, Jan A Burger
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis. British journal of haematology 184 (4) (2018)
Jan A Burger, Mariela Sivina, Nitin Jain, Ekaterina Kim, Tapan Kadia, Zeev Estrov, Graciela M Nogueras-Gonzalez, Xuelin Huang, Jeffrey Jorgensen, Jianling Li, Mei Cheng, Fong Clow, Maro Ohanian, Michael Andreeff, Thomas Mathew, Philip Thompson, Hagop Kantarjian, Susan O'Brien, William G Wierda, Alessandra Ferrajoli, Michael J Keating
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia. Blood 133 (10) (2018)
Shilpa Paul, Nitin Jain, Alessandra Ferrajoli, Susan O'Brien, Jan A Burger, Michael Keating, William G Wierda
A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia. British journal of haematology 185 (3) (2018)
Jan A Burger
Obinutuzumab: the more the merrier? Blood 127 (1) (2016)